<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-142 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-142</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-142</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-2.html">extraction-schema-2</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <p><strong>Paper ID:</strong> paper-aa92f65e855b03ef50249268d6afc4829856fb2d</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/aa92f65e855b03ef50249268d6afc4829856fb2d" target="_blank">Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.</a></p>
                <p><strong>Paper Venue:</strong> Physiological Genomics</p>
                <p><strong>Paper TL;DR:</strong> Significant regional differential expression in AD brains compared with control brains including expression changes of genes previously implicated in AD pathogenesis are identified, particularly with regard to tangle and plaque formation.</p>
                <p><strong>Cost:</strong> 0.021</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e142.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e142.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EC layer II stellate</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Layer II stellate neurons of the entorhinal cortex</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Excitatory stellate neurons in layer II of the entorhinal cortex that are among the earliest and most vulnerable neuronal types to neurofibrillary tangle formation in Alzheimer's disease.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Layer II stellate neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Large stellate neurons located in layer II of the entorhinal cortex (EC); identified morphologically and by location and selected only if Thioflavin-S negative (non-tangle-bearing) for laser capture microdissection.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>highly susceptible (early NFT formation)</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Entorhinal cortex (EC), layer II</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Early-stage susceptibility to NFT formation (Braak stages I–IV referenced as stages where EC is affected)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>No cell-loss percentage reported; regional molecular analyses: 922 genes showed statistically significant changes overlapping between EC and hippocampus (region-level). Heat map selection used a minimum fold-change threshold of ~9.5 for EC (for the top ~40 genes displayed), but no per-cell quantitative survival metrics were reported.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Neurofibrillary tangles (intracellular hyperphosphorylated tau / PHFs); associated with tau pathology and upstream molecular changes.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Proposed mechanisms include early engagement in tau hyperphosphorylation pathways (kinase activity such as CDK5/GSK3β dysregulation), impaired chaperone-mediated tau degradation (reduced STUB1/CHIP and Hsp70 family expression), disruptions in microtubule/tubulin dynamics (decreased MAPT and tubulin isoforms), and metabolic/synaptic vulnerabilities (synaptic transmission and glycolysis processes enriched in EC/HIP differentially expressed genes).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>Not specifically described for layer II stellate neurons; the paper suggests some neurons may enact protective transcriptional responses (e.g., decreased MAPT/tubulin expression) that could represent attempts to lower substrate availability for aggregation, but overall EC layer II neurons are characterized primarily as vulnerable.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>Observed in EC non-tangle-bearing neurons: decreased MAPT (tau) expression; decreased expression of multiple alpha/beta tubulin isoforms (TUBA1/2/3/6, TUBB variants); decreased STUB1/CHIP and multiple Hsp70 family members; altered expression of kinases and calpain subunits (CDK5 decreased, calpain subunits CAPN1/2/3/CAPNS1 altered); changes in PI3K/Akt, PKA, CaMKII, and GSK3β regulatory elements (region-specific).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>EC layer II stellate neurons are described as among the first neurons to be affected by tangle formation and thus more vulnerable than neurons in later-affected/spared regions (e.g., VCX); EC (and HIP) show overlapping gene-expression perturbations not seen in spared regions (SFG, VCX).</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Human postmortem tissue; Thioflavin-S + neutral red staining to exclude tangle-bearing cells; laser capture microdissection (≈500 non-tangle-bearing neurons per region per individual); Affymetrix Human Genome U133 Plus 2.0 microarrays; statistical analysis with FDR-corrected t-tests; pathway analyses; some RT-PCR validation performed on other regions (MTG, PC).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e142.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e142.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CA1 pyramidal</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>CA1 pyramidal neurons of the hippocampus</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>CA1 region pyramidal neurons in hippocampus which are classically early and heavily affected by neurofibrillary tangle pathology in Alzheimer's disease and were specifically profiled (non-tangle-bearing) in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>CA1 pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Pyramidal cells located in the CA1 subfield of the hippocampus; selected by morphology and lack of Thioflavin-S fluorescence to capture histopathologically normal (non-tangle-bearing) neurons for expression profiling.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>highly susceptible (early and heavy NFT formation)</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Hippocampus (CA1)</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Early-stage susceptibility to NFT formation (CA1 selected because it is earliest and most heavily affected region in HIP for tangle formation)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>No direct cell-loss percentages reported; region-level results: 5,315 genes identified in HIP analysis as significantly different (P<0.01 corrected) between AD and control; minimum fold-change threshold used for heatmap display in HIP was ~5.8 (top ~40 genes), but no per-cell survival metrics were given.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Neurofibrillary tangles (tau hyperphosphorylation/PHFs) and associated downstream changes; also considered in relation to amyloid-beta effects.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Mechanistic explanations include activation of tau-phosphorylating kinases (CDK5 activation via p25 produced by calpain cleavage of p35), potential GSK3β-mediated phosphorylation, alterations in chaperone and proteasomal systems (decreased STUB1/CHIP and Hsp70s), and impaired protein clearance pathways (ubiquitin-proteasome dysregulation, decreased UCHL1).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>Paper notes decreased expression of some kinases (CDK5) and of MAPT/tubulin in profiled non-tangle-bearing neurons, which the authors interpret as potential neuroprotective transcriptional responses to limit substrate for aggregation; however, overall CA1 pyramidal neurons are classed as vulnerable.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>Decreased MAPT (tau) expression; decreased tubulin isoforms; downregulation of chaperone/cochaperone STUB1/CHIP and various Hsp70 proteins in HIP; decreased GSK3β (with some probe exceptions); altered expression of CDK5R1 (p35) up in HIP; BACE1 decreased in HIP while APP increased in HIP; ubiquitin-proteasome subunits and enzymes broadly dysregulated; UCHL1 decreased in HIP.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>CA1 pyramidal neurons / HIP and EC neurons show overlapping signatures of vulnerability (922 genes overlapping between EC and HIP), and are more vulnerable to NFT formation relative to neurons from SFG and VCX which are affected later or relatively spared.</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Human postmortem hippocampal tissue; selection of non-tangle-bearing CA1 pyramidal neurons by Thioflavin-S staining and morphology; laser capture microdissection of ~500 neurons per region; two-round RNA amplification; Affymetrix microarrays; differential expression analysis with FDR correction; pathway analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e142.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e142.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Cortical layer III pyramidal</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Layer III pyramidal neurons (cortical corticocortical projection neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons across multiple cortical regions (MTG, PC, SFG, VCX) that are major corticocortical projection neurons and are selectively vulnerable to neurofibrillary tangle formation in AD, but show region-dependent susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Layer III pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Pyramidal neurons from cortical layer III, collected from MTG, PC, SFG, and VCX when Thioflavin-S negative; described as major corticocortical projection neurons responsible for inter-regional cortical communication and higher cognitive functions.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>region-dependent: vulnerable in some areas (MTG, PC) and relatively spared in others (VCX); overall moderately-to-highly vulnerable depending on region</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Middle temporal gyrus (MTG), posterior cingulate cortex (PC), superior frontal gyrus (SFG), primary visual cortex (VCX) — layer III</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Variable: MTG and PC noted as regions with elevated susceptibility to amyloid plaque formation and metabolic changes; VCX described as relatively spared (later-stage or minimal pathology).</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>No cell-loss percentages reported; region-level counts of significant genes: MTG analysis produced 7,687 significant genes, PC 4,886 significant genes; MTG and PC overlap produced 2,586 significantly changed genes. For heatmaps, fold-change thresholds were MTG ~8.2 and PC ~5.8 (top gene sets). RT-PCR validated downregulation of selected synaptic and cytoskeletal genes (SYP, MAP2, MAP1B, CHRM1, GRIA1) in MTG with p-values < ~0.05; exact fold-changes for RT-PCR not reported in-text.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Associated with both amyloid-beta plaque vulnerability (MTG and PC) and tau/NFT-related processes (layer III pyramidal neurons are selectively vulnerable to tangles in neocortex).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Potential mechanisms include high corticocortical connectivity (greater metabolic/synaptic burden), synaptic dysfunction (downregulation of synaptic genes such as SYP, SYNPR, GRIA1), metabolic deficits (glycolysis-related pathways), dysregulation of tau processing and chaperone systems (MAPT/tubulins decreased, STUB1/Hsp70 changes), and altered APP-processing gene expression (APP up, BACE1 down in several regions, SORL1 down).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>In spared regions (e.g., VCX and to some extent SFG), fewer expression changes were observed and enriched processes included cell organization, morphogenesis, and biogenesis; these features are suggested to contribute to neuroprotection. Also, decreased expression of MAPT/tubulins in some neurons may reflect local protective transcriptional responses to reduce aggregation substrate.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>Region-dependent molecular alterations: MTG and PC show increases in APP and alterations in secretase components (TMP21 up, APH1A up in some regions; BACE1 down in EC/HIP/MTG; BACE2 up in EC/MTG/PC/VCX); downregulation of synaptic genes (SYP, SYNPR), cytoskeletal genes (MAP2, MAP1B), SORL1 decreased in HIP/MTG/PC, PRDX2 decreased across many cortical regions; proteasome and ubiquitin pathway components broadly dysregulated.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>Layer III pyramidal neurons in MTG/PC display greater amyloid/plaque-associated molecular perturbations compared with neurons in SFG and VCX; VCX neurons exhibited the fewest expression changes overall and are characterized as relatively spared/resilient.</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Human postmortem cortical tissue; Thioflavin-S staining to exclude tangle-bearing neurons; laser capture microdissection (~500 neurons per region per individual); Affymetrix microarrays; differential expression with FDR correction; pathway analysis and RT-PCR validation for selected synaptic/cytoskeletal transcripts in MTG and PC.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e142.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e142.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Layer V pyramidal (mention)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Layer V pyramidal neurons (cortical)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Cortical layer V pyramidal neurons are noted as vulnerable to tangle formation but were reported to be less numerous and more difficult to collect for array analysis in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Layer V pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Pyramidal neurons located in cortical layer V; recognized as a neuronal population vulnerable to neurofibrillary tangle pathology but less numerous in the regions/lamina selected for this laser-capture expression study.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>susceptible (mentioned as vulnerable to tangle formation)</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Cortical regions (general cortical layer V) — mentioned in context of entorhinal cortex/neocortex vulnerability</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Not specifically staged in this paper; referenced as among neurons affected by tangle formation (intermediate/early in some cortical areas).</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>No quantitative measures provided; explicitly stated that layer V pyramidal neurons are less numerous and more difficult for array analysis, so they were not the primary target for capture.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Neurofibrillary tangles (tau pathology) — mentioned as one of the vulnerable neuronal populations.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Not experimentally examined in this study; vulnerability is asserted based on prior literature and laminar distribution of NFT pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>Not applicable / not described.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>Not profiled in this dataset (no LCM array data specific to layer V reported); hence no molecular features reported in this paper for this cell type.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>Mentioned as vulnerable but less numerous compared to layer II stellate and layer III pyramidal neurons; therefore less amenable to the authors' LCM/array approach.</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Mention only; no direct profiling. Context derived from neuropathological literature cited by the authors.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e142.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e142.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>VCX layer III pyramidal</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Layer III pyramidal neurons of primary visual cortex (VCX)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons from primary visual cortex that were profiled and described as relatively spared from AD-related pathological and gene-expression changes compared with other cortical regions.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Layer III pyramidal neurons (primary visual cortex)</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Pyramidal neurons from layer III of primary visual cortex (Brodmann area 17); collected when Thioflavin-S negative; representative of a primary sensory region relatively spared in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>resilient / relatively spared</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Primary visual cortex (VCX, BA 17), layer III</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Relatively spared across age/disease stages; affected in later Braak stages (V–VI) but generally shows minimal pathology in earlier stages according to literature cited.</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>Fewest expression differences observed among profiled regions; VCX heatmap top-gene fold-change threshold used was ~2.4 (smaller changes vs other regions); number of significant genes for VCX analysis: 2,058 (P<0.01 corrected) but with smaller fold changes overall; no cell loss percentages reported.</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Relatively low exposure to both neurofibrillary tangles and amyloid plaque pathology in most stages (described as spared from age- or disease-related neurodegeneration).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Not susceptible; the paper suggests resilience may be linked to fewer perturbations in key pathways (cell physiological processes, cellular localization, transport) and less engagement of pathways implicated in NFT/plaque formation.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>Proposed explanations include limited transcriptional perturbation in VCX (fewer differentially expressed genes and smaller fold-changes), maintenance of cellular transport/localization and metabolic processes, and less involvement in the large-scale corticocortical connectivity that may impose metabolic/synaptic stress.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>VCX showed smaller magnitude expression changes across the same AD-related gene sets; APP increased in VCX while many kinase and chaperone changes seen in tangle-susceptible regions were less pronounced here; however specific protective gene-expression signatures are not definitively singled out beyond the observation of fewer changes.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>VCX neurons show markedly fewer and smaller gene expression changes compared with neurons from EC, HIP, MTG, and PC; SFG/VCX considered more spared/affected later vs EC/HIP and MTG/PC which are more susceptible.</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Human postmortem VCX tissue; Thioflavin-S negative layer III pyramidal neurons isolated by LCM; Affymetrix U133 Plus 2.0 arrays; differential expression analysis and pathway analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e142.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e142.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MTG/PC layer III pyramidal (plaque-susceptible)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Layer III pyramidal neurons of middle temporal gyrus and posterior cingulate cortex (plaque-susceptible cortical neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer III pyramidal neurons in MTG and PC that display elevated susceptibility to amyloid-beta plaque-related pathology and metabolic changes, with marked region-specific gene-expression perturbations in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Layer III pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type_description</strong></td>
                            <td>Cortical layer III pyramidal neurons from middle temporal gyrus (MTG; BA 21/37) and posterior cingulate cortex (PC; BA 23/31); non-tangle-bearing at time of capture; implicated in regions with elevated amyloid plaque deposition and metabolic deficits.</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_classification</strong></td>
                            <td>vulnerable to amyloid-beta plaque pathology (moderately to highly vulnerable regionally)</td>
                        </tr>
                        <tr>
                            <td><strong>brain_region</strong></td>
                            <td>Middle temporal gyrus (MTG) and posterior cingulate cortex (PC), layer III</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Regions noted as plaque-susceptible and metabolically altered in AD (plaques typically prominent in temporal and posterior cingulate neocortex; staging variable across disease progression).</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>MTG analysis identified 7,687 significant genes (P<0.01 corrected) and PC 4,886 significant genes; overlap between MTG and PC yielded 2,586 significant genes; RT-PCR on unprofiled MTG showed significant downregulation of SYP, MAP2, MAP1B, CHRM1, and GRIA1 (p-values reported, exact fold-changes not provided in-text).</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_exposure</strong></td>
                            <td>Extracellular amyloid-beta plaques (neuritic plaques) and associated metabolic deficits; also likely implicated in tau-related downstream processes.</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_susceptibility</strong></td>
                            <td>Proposed mechanisms include active APP processing (APP increased in MTG/PC), altered secretase component expression (TMP21, APH1A, PSEN1 variations), impaired Aβ clearance machinery (SORL1 decreased; variable APOE, A2M, LRP expression), synaptic dysfunction (downregulation of synaptic genes), and disturbances in microtubule-based transport and axonal cargo mechanisms (GeneGo processes enriched).</td>
                        </tr>
                        <tr>
                            <td><strong>mechanism_of_resilience</strong></td>
                            <td>Not prominent in these regions; some upregulation of putative protective factors (e.g., BACE2 upregulation in MTG/PC, GGA1 up in PC which may reduce BACE1-mediated APP cleavage) may represent attempts at protection, but overall these regions show strong pathology-associated perturbations.</td>
                        </tr>
                        <tr>
                            <td><strong>molecular_features</strong></td>
                            <td>APP increased in MTG and PC; BACE1 decreased in several regions including MTG, whereas BACE2 increased in MTG/PC; TMP21 (TMED10) increased in MTG/PC; APH1A increased in MTG; SORL1 decreased in MTG/PC; APOE increased in MTG (decreased in PC); A2M increased in MTG; GGA1 markedly increased in PC; synaptic and cytoskeletal genes (SYP, MAP2, MAP1B, GRIA1, SYNPR) downregulated (validated by RT-PCR in MTG/PC); ubiquitin-proteasome pathway components dysregulated (UBQLN1, UCHL1 decreased in cortical regions).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_to_other_cells</strong></td>
                            <td>MTG/PC neurons show more pronounced amyloid-related molecular perturbations than neurons from SFG/VCX (spared regions), and they cluster as plaque-susceptible regions compared with EC/HIP which are tangle-susceptible (though there is overlap in affected pathways).</td>
                        </tr>
                        <tr>
                            <td><strong>methodology</strong></td>
                            <td>Thioflavin-S screening to exclude tangles; LCM of ≈500 non-tangle-bearing layer III pyramidal neurons per region per subject; Affymetrix microarrays; differential expression analysis with multiple-testing correction; pathway enrichment (GeneGo/MetaCore); RT-PCR validation for selected transcripts on separate unprofiled tissue.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.", 'publication_date_yy_mm': '2008-04'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Gene expression correlates of neurofibrillary tangles in Alzheimer's disease <em>(Rating: 2)</em></li>
                <li>Neuropathological staging of Alzheimer-related changes <em>(Rating: 2)</em></li>
                <li>Phases of A beta-deposition in the human brain and its relevance for the development of AD <em>(Rating: 2)</em></li>
                <li>The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease <em>(Rating: 2)</em></li>
                <li>CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation <em>(Rating: 2)</em></li>
                <li>A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration <em>(Rating: 1)</em></li>
                <li>Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>